Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience

Affiliations

Ouissam Al jarroudi: Medical Oncology Department AP‐HPPaul Brousse Hospital Villejuif France
Hamed Chaabouni: Medical Oncology Department AP‐HPPaul Brousse Hospital Villejuif France
Ayhan Ulusakarya: Medical Oncology Department AP‐HPPaul Brousse Hospital Villejuif France
Wathek Almohamad: Medical Oncology Department AP‐HPPaul Brousse Hospital Villejuif France
Yusuf Gumus: Medical Oncology Department AP‐HPPaul Brousse Hospital Villejuif France
Emma Goldschmidt: Medical Oncology Department AP‐HPPaul Brousse Hospital Villejuif France
Said Afqir: Medical Oncology Department University Hospital Mohammed VI‐Oujda Oujda Morocco
Jean‐francois Morère: Medical Oncology Department AP‐HPPaul Brousse Hospital Villejuif France

Abstract

Abstract Nivolumab is an effective and safe treatment in HCC.